PEDIATRIC LOW-GRADE GLIOMA
Clinical trials for PEDIATRIC LOW-GRADE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new PEDIATRIC LOW-GRADE GLIOMA trials appear
Sign up with your email to follow new studies for PEDIATRIC LOW-GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug trial offers new hope for kids with brain tumors
Disease control Recruiting nowThis study is testing a new oral drug called tovorafenib (DAY101) against standard chemotherapy for children and young adults with a specific type of slow-growing brain tumor. The goal is to see if the new drug is more effective at shrinking tumors and controlling the disease, an…
Matched conditions: PEDIATRIC LOW-GRADE GLIOMA
Phase: PHASE3 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New Two-Drug combo tested for Kids' brain tumors
Disease control Recruiting nowThis study is testing a new combination of two drugs, mirdametinib (taken by mouth) and vinblastine (given by IV), for children and young adults with a specific type of slow-growing brain tumor. The main goals are to find the safest dose of the drug combination and to see how wel…
Matched conditions: PEDIATRIC LOW-GRADE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Justine's Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC